VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 676 filers reported holding VANECK VECTORS ETF TR in Q3 2021. The put-call ratio across all filers is 1.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,077,000 | -77.6% | 39,375 | -68.7% | 0.35% | -73.5% |
| Q1 2022 | $4,817,000 | +19.4% | 125,915 | 0.0% | 1.30% | +18.6% |
| Q4 2021 | $4,033,000 | +9.1% | 125,915 | 0.0% | 1.10% | +6.4% |
| Q3 2021 | $3,698,000 | -13.0% | 125,915 | +0.6% | 1.03% | -17.4% |
| Q2 2021 | $4,251,000 | -15.4% | 125,127 | -12.1% | 1.25% | +31.7% |
| Q1 2021 | $5,025,000 | -99.9% | 142,320 | +2.3% | 0.95% | -89.5% |
| Q4 2020 | $5,011,102,000 | +5113269.4% | 139,120 | +5473.7% | 9.10% | +32389.3% |
| Q3 2020 | $98,000 | -97.3% | 2,496 | -97.5% | 0.03% | -94.6% |
| Q2 2020 | $3,616,000 | +8309.3% | 98,592 | +5209.2% | 0.52% | +8616.7% |
| Q4 2019 | $43,000 | – | 1,857 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |